Certain types of human light chains have the propensity to deposit pathologically as
amyloidfibrils as evidenced by the preferential association of monoclonal
![](/images/gifchars/lambda.gif)
6 proteins with AL
amyloidosis.However, the molecular features that render such proteins
amyloidogenic have not been elucidated. Basedupon the demonstrated relationship between the thermodynamic stability of light chains and their propensityto aggregate in vitro, we have initiated studies where the thermodynamic properties and fibrillogenicpotential of two recombinant (r) V
![](/images/gifchars/lambda.gif)
6 molecules were compared. The first protein was generated fromcDNA cloned from marrow-derived plasma cells from a patient (Wil) who had AL
amyloidosis and renal
amyloid deposits; the second was from a patient (Jto) with multiple myeloma in whom the
![](/images/gifchars/lambda.gif)
6 proteinwas deposited not as
amyloid but in the form of renal tubular casts. The thermodynamic stabilities ofrV
![](/images/gifchars/lambda.gif)
6Wil and -Jto were determined from chaotropic and thermal denaturation studies. Based upon the
GH2O,
H,
G25
C,
Tm, and
Cm values, the rV
![](/images/gifchars/lambda.gif)
6Wil was less stable than its non
amyloidogenic counterpart,rV
![](/images/gifchars/lambda.gif)
6Jto. Measurement of fibril formation using a novel in vitro fibril forming assay demonstrated thatalthough both rV
![](/images/gifchars/lambda.gif)
6 proteins formed fibrils in vitro, Wil had a shorter lag time and exhibited faster kineticsunder physiologic conditions. Comparative amino acid sequence analyses of these two components andother
![](/images/gifchars/lambda.gif)
6
amyloid-associated light chains revealed that the Jto protein had certain primary structural featuresthat we posit contributed to its increased stability and thus rendered this protein non
amyloidogenic. Ourstudies provide the first evidence that stabilizing interactions within the V
L domain can influence thekinetics of light chain fibrillogenicity.